NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nalagenetics

Nalagenetics

Private
SingaporeHealthcare & Life Scienceshttps://www.nalagenetics.com/en

Last Round

Series A

Mar 25, 2022

Total Funding Raised

$13.6M

Company Overview

Nalagenetics is a biotechnology company that provides genetic testing and clinical decision support software to enable personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Vertical SaaS, Healthcare Analytics, Medical AI

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

clinical decision supportpharmacogenomicsCDSPGxAsian geneticsgenetic testingprecision medicineadverse drug reactionbioinformatics softwaremedical AIcancer risk screeninghereditary cancer testingnutrigeneticspolygenic risk scoresNIPT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nalagenetics Comparables

Compare Nalagenetics with similar companies based on industry and business-model similarity.

Nalagenetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Nalagenetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 25, 2022
Pre SeedNov 1, 2018

Nalagenetics Investors

Notable investors and investment history

Nalagenetics investors
InvestorRounds
Intudo VenturesPre Seed, Series A
AngelCentralPre Seed
Integra PartnersSeries A
Accelerate Technologies Pte LtdSeries A
Vulcan CapitalSeries A
East VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors increased 49% MoM, reaching 6.4K.

  • Jul 24, 2023

    Grew 20% QoQ, from 80 to 96 employees.

Nalagenetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nalagenetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nalagenetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range52
Year Founded2016
Last FundingMar 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.